Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer-specific mortality, according to a review published online May 15 in the Cochrane Database of Systematic ...

NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...

Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with ...

A free June cooking demonstration series in Oxford will focus on nutrition strategies tied to men’s health, cancer risk reduction, and healthy aging.The Griffin Center for Healthy Living at Quarry ...

Detailed results from pivotal TALAPRO-3 study presented at ASCO 2026 and published in The New England Journal of Medicine TALZENNA plus XTANDI demonstrated a 52% reduction in the risk of radiographic ...

Routine prostate cancer screening has been rejected by the UK's independent screening committee despite significant pressure ...

Among men with high-risk localized prostate cancer, those receiving neoadjuvant apalutamide combination therapy had improved potency recovery by 12 months and reduced rates of positive margins ...

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review ...

Research found that the weight-loss medications may reduce the spread of several obesity-related cancers, including lung, ...

Study showed immediate improvement in symptoms after intentional retrieval of device at 6 ...

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the Interventional Urology Business Unit has released new clinical data across two major ...